Domestic Presence

INDIA

Currently ranked at 3rd largest manufacturer in its segment in the Indian Pharmaceutical Market, Axa is one of the fastest growing Indian pharmaceutical conglomerate. Driven by a sustainable business model, Axa has been consistently outperforming the market with more than 35% growth. Its 4 Strategic Business Units employ a multidivisional model, catering to various therapy areas for enhanced focus towards brand and market development. On the foundation of this diversified revenue base, Axa has gained a influential presence in India with an expanding market share and improving ranks across years.

The current emphasis is on Intravenous Fluids Therapy, Respiratory Segment Products, Ophthalmology including Preservative Free Single Dose Delivery System and Preservative Free Multi-dose Delivery Systems which is unique and the only one in India, along with General Injectables, Cephalosporins, Carbapenems, Anti-cancer Products including MABs (Monoclonal Antibodies). While Axa enjoys leadership status in the Intra-venous Fluids segment, it has also been rapidly gaining leadership in Oncology, Rheumatology, Ophthalmology and Respiratory segments.

Its upcoming Unit-II is already the talk of the town due to its diverse manufacturing capabilities and the Pharmaceutical segments it is going to cater to and also due to its tallest infrastructure. It has been built especially to cater to the Highly Regulated Markets of the Globe line Europe, Australia, United Kingdom and US Pharmaceutical markets.